| Gary Raymond Decker, MD | |
|
545 N River St, Suite 205, Wilkes Barre, PA 18702-2600 | |
| (570) 822-6036 | |
| (570) 829-1520 |
| Full Name | Gary Raymond Decker |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 32 Years |
| Location | 545 N River St, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144279209 | NPI | - | NPPES |
| 0012845610001 | Medicaid | PA | |
| 075321 | Other | PA | FIRST PRIORITY HEALTH |
| 8408 | Other | PA | GEISINGER HEALTH PLAN |
| 102861 | Other | PA | UNISON HEALTH PLAN |
| 710341 | Other | PA | HIGHMARK BLUE SHIELD |
| 710341 | Other | PA | FIRST PRIORITY LIFE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD042296E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Regional Hospital Of Scranton | Scranton, PA | Hospital |
| Wilkes-barre General Hospital | Wilkes-barre, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wyoming Valley Infectious Disease Assoc, Pc | 9234176058 | 2 |
News Archive
National Psoriasis Foundation will double the number of researchers studying psoriasis and psoriatic arthritis while also cutting in half the number of people who say these chronic conditions are a problem in their daily lives as part of its new five-year strategic plan and mission to cure psoriatic disease and improve the lives of those affected.
A UT Southwestern study is challenging concerns that a federal health policy enacted in 2012 to reduce hospital readmissions leaves patients more vulnerable.
Genentech, the maker of Avastin, will appeal to the Food and Drug Administration to make its drug available as a treatment for breast cancer — asking for one more chance to prove its efficacy.
Facial paralysis is a devastating condition that affects a patient's ability to express emotions and has numerous esthetic as well as functional consequences.
› Verified 8 days ago
| Entity Name | Wyoming Valley Infectious Disease Assoc, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372373 PECOS PAC ID: 9234176058 Enrollment ID: O20050413000781 |
News Archive
National Psoriasis Foundation will double the number of researchers studying psoriasis and psoriatic arthritis while also cutting in half the number of people who say these chronic conditions are a problem in their daily lives as part of its new five-year strategic plan and mission to cure psoriatic disease and improve the lives of those affected.
A UT Southwestern study is challenging concerns that a federal health policy enacted in 2012 to reduce hospital readmissions leaves patients more vulnerable.
Genentech, the maker of Avastin, will appeal to the Food and Drug Administration to make its drug available as a treatment for breast cancer — asking for one more chance to prove its efficacy.
Facial paralysis is a devastating condition that affects a patient's ability to express emotions and has numerous esthetic as well as functional consequences.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary Raymond Decker, MD 545 N River St, Suite 205, Wilkes Barre, PA 18702-2600 Ph: (570) 822-6036 | Gary Raymond Decker, MD 545 N River St, Suite 205, Wilkes Barre, PA 18702-2600 Ph: (570) 822-6036 |
News Archive
National Psoriasis Foundation will double the number of researchers studying psoriasis and psoriatic arthritis while also cutting in half the number of people who say these chronic conditions are a problem in their daily lives as part of its new five-year strategic plan and mission to cure psoriatic disease and improve the lives of those affected.
A UT Southwestern study is challenging concerns that a federal health policy enacted in 2012 to reduce hospital readmissions leaves patients more vulnerable.
Genentech, the maker of Avastin, will appeal to the Food and Drug Administration to make its drug available as a treatment for breast cancer — asking for one more chance to prove its efficacy.
Facial paralysis is a devastating condition that affects a patient's ability to express emotions and has numerous esthetic as well as functional consequences.
› Verified 8 days ago
Dr. Paul Anthony Arkless, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Dr, Pulmonary Department, Wilkes Barre, PA 18711 Phone: 570-808-5770 | |
Dr. Lida Eatedali, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1111 East End Blvd, Vamc., Wilkes Barre, PA 18711 Phone: 570-824-3521 | |
Dr. Sanjaykumar Doshi, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: Va Medical Center, 1111 East End Blvd, Wilkes Barre, PA 18702 Phone: 570-824-3521 | |
Dr. Smita S. Nikam, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-820-6114 Fax: 570-826-7698 | |
Carol L Myers, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-6444 Fax: 570-808-5040 | |
Patrick Michael Aquilina, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 545 N River St Ste 240, Wilkes Barre, PA 18702 Phone: 570-819-2825 Fax: 570-819-1445 | |
Dr. Richard Abbas Alley, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 166 Hanover St, 203, Wilkes Barre, PA 18702 Phone: 570-825-8780 Fax: 570-825-8785 |